But
the active ingredients in this class of drugs, marketed under a variety
of names, are also getting attention for effectiveness in reducing
obesity. The respected journal, Lancet, predicts a revolution in the treatment of obesity.
How
do these drugs work? Ozempic reduces blood sugar level while providing a
feeling of fullness and satisfaction after eating, delaying emptying of
the stomach, and curbing the appetite for further food. Managing food
intake is essential in the fight against type 2 diabetes.
But
weight loss is proving a beneficial side effect of Ozempic. People can
expect to lose about 20 percent of their weight over a 72-week period.
When Ozempic is stopped, however, weight tends to return. So, to the
current trend is for people to maintain a regular routine of use.
What
about complications? Ozempic users complain of the usual ones such as,
nausea, vomiting, diarrhea, constipation, and stomach pain. In rats,
tests show an increase in thyroid and pancreatic cancers. In humans,
research to date suggests extremely low risk.
People
may ask, why take the chance of developing thyroid or pancreatic
cancer? But wait a minute. These are relatively rare forms of cancer
driven by other risk factors.
Type
2 diabetes and obesity are far more significant hazards, triggering
fatalities for millions. Weight reduction and management of type 2
diabetes are the smart investments. The better question is, could these
drugs help millions who die annually from cardiovascular disease and
heart failure? We could add renal disease, liver disease, and pneumonia,
as well as additional but harder to count problems such as the surgical
complications associated with diabetes and obesity.